Navigation Links
USAMRIID research sheds light on how deadly lassa virus infects cells
Date:6/27/2014

Scientists have discovered that the Lassa virus, which is endemic to West Africa, uses an unexpected two-step process to enter cells. The results, published in today's edition of the journal Science, suggest that the mechanism by which Lassa virus causes infection is more complicated than previously known.

An international team of scientists from the Netherlands Cancer Institute, Harvard Medical School, the University of Kiel in Germany, and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) collaborated on the study, which could lead to new approaches for preventing the disease.

"This research indicates that viruses may require multiple receptors for delivering their viral cargo for productive infection, which is a fresh way of looking at classical viral entry," said John M. Dye, Jr., Ph.D, of USAMRIID.

According to the authors, it has been known for more than three decades that while Lassa virus can infect a broad range of cells from different species, it does not infect chickensdespite the fact that bird cells have the necessary receptor, or protein, that the virus uses to enter cells. Thus, some additional mechanism appeared to be at work.

Scientists at the Netherlands Cancer Institute and Harvard Medical School discovered that when Lassa virus latches on to its receptor on the cell surface, it is first transported to a structure inside the cell called a lysosome. Lysosomes have been dubbed the "garbage cans" of cells because they break down a variety of molecules. Therefore, in order to infect the cell, Lassa virus needs to escape the lysosome. It does so by hooking onto a protein called LAMP1a previously undiscovered interior cell receptor for the virus.

"From a virology point of view, this second part of our discovery is the most interesting," said first author Lucas Jae of the Netherlands Cancer Institute. "The identity of the receptor on the cell surface has been known for 15 years. Nobody expected there to be a second receptor, inside of the cell."

The genetic findings were confirmed by Dye and his teamAndrew Herbert, Ph.D., Ana Kuehne and Ariel Wirchnianskiwho demonstrated that mice specially bred to lack the LAMP1 protein were protected from infection with the Lassa virus. This work, performed at USAMRIID using authentic Lassa virus, was critical for validating the role of LAMP1 in Lassa virus infection. Such research can be conducted only in maximum containment Biosafety Level 4, or BSL-4, laboratories, where investigators wear positive-pressure suits and breathe filtered air as they work.

"The discovery of novel intracellular receptors for viruses, like LAMP1 for Lassa virus, opens the door for the development of therapeutics directed against these previously unknown targets," said Dye.

Lassa virus causes a severe hemorrhagic fever that is 20 to 50 percent fatal in humans, and results in permanent hearing loss in about one-third of those who survive. An estimated 500,000 cases and 100,000 deaths occur each year in West Africa. The disease also affects health care workers in endemic areas, who may lack the necessary equipment to maintain barrier nursing precautions that can keep the disease from spreading.

Funding for the work was provided by the European Research Council (ERC), the National Institutes of Health (NIH), and the Defense Threat Reduction Agency (DTRA).

USAMRIID, located at Fort Detrick, Maryland, is the only Department of Defense laboratory with BSL-4 capability. The Institute's mission is to protect the warfighter from biological threats and to be prepared to investigate disease outbreaks or threats to public health. Research conducted at USAMRIID leads to medical solutionsvaccines, drugs, diagnostics, and informationthat benefit both military personnel and civilians.

The Institute plays a key role as the lead military medical research laboratory for DTRA's Joint Science and Technology Office for Chemical and Biological Defense. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Materiel Command.


'/>"/>

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases
Source:Eurekalert

Related biology news :

1. Autism speaks announces Meixner Postdoctoral Fellowships in translational research
2. EU project Bestcilia project pushes the research of primary ciliary dyskinesia forward
3. CNIO researchers discover more than 40 melanoma-specific genes that determine aggressiveness
4. Research provides new theory on cause of ice age 2.6 million years ago
5. Chimps like listening to music with a different beat, research finds
6. Researchers discover Trojan Horse method of penetrating cellular walls without harm
7. People with tinnitus process emotions differently from their peers, researchers report
8. UMN research uncovers structure, protein elements critical to human function and disease
9. LSTM Researchers demonstrate adaptive potential of hybridization in mosquito species
10. Researcher shines light on the search for new drugs
11. Research explains action of drug that may slow aging, related disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
Breaking Biology Technology: